<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="365978">
  <stage>Registered</stage>
  <submitdate>22/04/2014</submitdate>
  <approvaldate>17/06/2014</approvaldate>
  <actrnumber>ACTRN12614000639628</actrnumber>
  <trial_identification>
    <studytitle>Comparison of transversus abdominis plane block continuous catheter infusion vs intermittent bolus dosing for postoperative pain relief in abdominal surgery.-Prospective randomised study.</studytitle>
    <scientifictitle>Comparison Transversus abdominis plane block continuous catheter infusion vs intermittent bolus dosing for postoperative analgesia in abdominal surgery- Prospective randomized study.</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>none</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Study of postoperative pain scores and analgesia between the groups</healthcondition>
    <healthcondition>Quality of pain relief(satisfaction scores) and cost of pain relief methods</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Pain management</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>In the continous group under ultrasound guidance TAP block performed and catheter inserted,thru the catheter the anaesthetist boluses ropivacaine 0.5% 20ml on each side, followed by ropivacaine 0.2% infusion @ 8ml/hr each side in recovery room till 48hrs. whereas in Intermittent group with same technique and same bolus dose as other gp but subsequent bolus of 0.2% ropivacaine 20ml each side delivered by pain service team at 8hours intervel till 48hrs.
Patients in both groups will be provided with Paracetamol 1 gram 4 times a day (orally or IV) and a Fentanyl PCA device (bolus 10 to 40 mcg; lockout time 5 min; no back-ground infusion) as part of a multimodal analgesic approach</interventions>
    <comparator>Under ultrsound guide, bilateral TAP block will be performed in both the groups.In the continous group the bolus dose of ropivacaine 0.5% 20ml on each side followed by ropivacaine 0.2% infusion @ 8ml/hr each side till 48hrs</comparator>
    <control>Active</control>
    <interventioncode>Prevention</interventioncode>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Pain scores on the numerating scale of 0-10
</outcome>
      <timepoint>  at 1 hour, 24 hours and 48 hours</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>other primary outcome would be analgesia used in the perioperativ period</outcome>
      <timepoint>time point in the immediate recovery period, at 24 hrs and 48hrs</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Satisfaction scores 
Likert scale for satisfaction with pain relief methods: 4 point rating used: 1. completely relieved; 2. relieved; 3. somewhat relieved; and 4. not relieved </outcome>
      <timepoint>on day 2 and 30 days</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>cost of consumables and labour</outcome>
      <timepoint>During the 48 hours
The cost of all the consumables and time consumed by the staff done by the nurse co-ordinator.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Discharge time</outcome>
      <timepoint>1st post operative week, data collected electronically fron hspital database</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Inclusion Criteria:
Elective abdominal surgery
Between 18 and 85 years of age
ASA less then 4
Adequate English language skills
</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>85</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Emergency surgery
Allergy to local anaesthetic 
Pregnancy 
On regular opioid medication prior to surgery 
Mental handicap or psychiatric condition precluding adequate communication
</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Transversus abdominis plane (TAP) block with catheter is inserted intra operatively in all cases but the method of local anaesthetic delivery in the post op period is either intermittent bolus or continous infusion group.
The allocation done by simple randomisation table created by computer software(computerised sequence generation). This allocation was concealed by sealed opaque envelope with numbered and group what alloted to .</concealment>
    <sequence>The allocation done by simple randomisation table created by computer software(computerised sequence generation). This allocation was concealed by sealed opaque envelope with numbered and group what alloted to .</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures>Its a prospective study approximately 10 in each group,randomised controlled trial, with patient and data collecting person are blinded</designfeatures>
    <endpoint>Efficacy</endpoint>
    <statisticalmethods>The data will be analysed using the following methods: differences between the
continuous variables by the t-test; categorical variables by Fisher's exact test. The pain scores between groups (Continuous vs Intermittent TAP) will be analysed by rank non-parametric methods (Man Whitney U test).
</statisticalmethods>
    <masking1>True</masking1>
    <masking2>False</masking2>
    <masking3>False</masking3>
    <masking4>True</masking4>
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>22/12/2014</anticipatedstartdate>
    <actualstartdate>22/12/2014</actualstartdate>
    <anticipatedenddate />
    <actualenddate>12/10/2015</actualenddate>
    <samplesize>20</samplesize>
    <actualsamplesize>20</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>12/11/2015</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>SA</recruitmentstate>
    <hospital>The Queen Elizabeth Hospital - Woodville</hospital>
    <postcode>5011 - Woodville</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>The Queen Elizabeth hospital</primarysponsorname>
    <primarysponsoraddress>TQEH dept of anaesthesia
28 woodville rd
woodville 5011.SA
</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>ThE queen Elizabeth hospital
Self funded</fundingname>
      <fundingaddress>Dept of anaesthesia TQEH
28 woodville rd
Woodville.5011 SA</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This prospective study 0f 20 patients.In both the groups Bilateral TAP catheters will be placed using an ultrasound guided approach post-operatively with the bolus dose of 20 ml of 0.5% Ropivacaine bilaterally. In post anaesthetic care unit (PACU) an infusion of Ropicavaine 0.2% will be administered @ 8ml/hr for 2 days in the Continuous group. Whereas in Intermittent group only bolus doses 20ml 0.2% ropivacaine will be administered by the Acute pain service personnell every 8 hrly for 48 hrs. 

Patients in both groups will be provided with Paracetamol 1 gram 4 times a day (orally or IV) and a Fentanyl PCA device (bolus 10 to 40 mcg; lockout time 5 min; no back-ground infusion) as part of a multimodal analgesic approach. 

The following parameters will be registered:
Numerical Rating Scores for Pain (NRS-P; 0-10) at rest and on coughing in PACU at 0 and I hour and in the postoperative ward at 24 hrs, 48 hrs. 
Fentanyl use in PACU and postoperative ward on day 1 &amp; day 2.
Procedure related: material costs and other issues will be noted.
Any rescue medication used. 
A 4 point Likert-scale will be used on day 2 and during a follow-up telephone call at one month to assess patient satisfaction with the analgesic technique used. 
discharge time and cost analysis will be assessed.

All results will be recorded on a data collection sheet in a prospective fashion and subsequently entered in a protected database</summary>
    <trialwebsite>nil</trialwebsite>
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>The Queen Elizabeth hospital Ethics committee </ethicname>
      <ethicaddress>28 woodville rd
woodville 5011.SA</ethicaddress>
      <ethicapprovaldate>8/10/2014</ethicapprovaldate>
      <hrec>HREC/14/TQEHLMH/116</hrec>
      <ethicsubmitdate>15/07/2014</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>vasanth rao kadam</name>
      <address>The Queen Elizabeth hospital,dept of anaesthesia,
28 woodville rd, Woodville.5011 SA</address>
      <phone>61882226000</phone>
      <fax>61882227065</fax>
      <email>vasanth.rao@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>vasanth rao kadam</name>
      <address>The Queen Elizabeth hospital,dept of anaesthesia,
28 woodville rd.Woodvile 5011.SA</address>
      <phone>61882226000</phone>
      <fax />
      <email>vasanth.rao@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Roelof Vanwijk</name>
      <address>The Queen Elizabeth hospital. dept of anaesthesia,
28 woodville rd Woodville SA 5011</address>
      <phone>61882226000</phone>
      <fax>61882227065</fax>
      <email>vasanth.rao@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>vasanth rao kadam</name>
      <address>dept of anaesthesia,
28 woodville rd</address>
      <phone>61882226000</phone>
      <fax />
      <email>vasanth.rao@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>